Didier Surdez

1 month ago | digitalcommons.library.tmc.edu | David Shulman |Sarah Whittle |Didier Surdez |Kelly Bailey

KeywordsSarcoma, Cancer genetics, Prognostic markers, Molecular medicineAbstractThe advent of dose intensified interval compressed therapy has improved event-free survival for patients with localized Ewing sarcoma (EwS) to 78% at 5 years. However, nearly a quarter of patients with localized tumors and 60-80% of patients with metastatic tumors suffer relapse and die of disease. In addition, those who survive are often left with debilitating late effects.